By Lindsey Elling
Each month she holds her breath for three minutes, waiting for a clear indication in the form of a pink plus sign. Every month the sign does not show. For the nearly 6.1 million women who deal with fertility issues, going month in and month out without conceiving becomes an emotional and physical roller coaster. According to the Center for Disease Control and Prevention, nearly 10 percent of women between the ages of 15 and 44 have fertility issues. Experts typically define infertility as “having one year of regular intercourse, two to three times weekly, with regular periods, without achieving pregnancy.”
For those 6.1 million women coping with infertility, the process not only takes a physical and emotional toll, but also can incur a financial burden for many couples. Many companies and organizations have developed a number of different treatments for infertility, but most are costly, time-consuming and effective only a small percentage of the time. The stakes are even higher for women over the age of 30. The so-called Bible for infertility, Clinical Gynecologic Endocrinology and Infertility, reports that "one third of women postponing pregnancy until their mid to late thirties will have an infertility problem, while half of those over age 40 will require medical assistance to conceive."
Research has found that with 75 percent of women with fertility problems, the main issue is a lack of natural lubrication during intercourse. In 2003, the National Center for Health Statistics and the Centers for Disease Control and Prevention found that 75 percent of infertile women experience vaginal dryness and lubrication insufficiency. Attempting to counteract vaginal dryness, many women turn to commercial vaginal lubricants, such as KY Jelly, Replens, Astroglide, and Femglide. Studies found that most of those products decrease sperm motility in vitro and some are even spermicidal, providing the exact opposite affect women desired when using them.
One product, brought on the market in 2012, promises to provide sufficient and effective natural lubrication, while increasing sperm mobility without killing sperm. ToConceive, developed by an OBGYN using Nobel-prize winning technology, concentrates on sperm capacitation, the process that allows the sperm to fertilize an egg. The act of conception can only take place two days a month and follows a complex process that requires all parts of the puzzle to work perfectly together.
A woman becomes aroused during sexual intercourse, producing the exact lubrication needed to help the sperm survive and function, and ultimately capacitate the sperm. Capacitation allows the sperm to move with whip-like motions to travel the six to seven inches into the ampulla, the far end of the fallopian tube where the mature egg is released by the ovary each month. Proper lubrication also helps balance the pH levels of the vagina and hydrate the cervical mucus, both of which lead to increased sperm function to fertilize the egg. Capacitation also allows the sperm to penetrate the egg for conception.
Applied directly to the clitoris, ToConceive helps the woman produce her own necessary natural lubrication that she may lack. That natural conception lubrication provides for optimum survival and function of the sperm, which leads to an increase odds of conception every cycle. For those 75 percent of infertile women experiencing a lack of proper lubrication, ToConceive offers a way for a woman to increase her own natural conception lubrication to promote sperm capacitation.
ToConceive offers hope to each of those women who sit waiting each month for that pink plus sign.